← Back to Search

End-of-Life Conversation Tools for Advance Care Planning

N/A
Recruiting
Led By Lauren J. Van Scoy, MD
Research Sponsored by Milton S. Hershey Medical Center
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Adults over the age of 18 years old in underserved populations
Able to speak and read English and/or Spanish
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 6 months post-intervention
Awards & highlights

Study Summary

This trial will test whether existing social networks can be used to help underserved people have conversations about end-of-life care and make plans accordingly.

Who is the study for?
This trial is for adults over 18 from underserved communities who can speak and read English or Spanish. They should not have completed an advance directive in the past 5 years. Community hosts must be able to gather 20 individuals, have experience with events and working with these populations, plus complete mandatory training.Check my eligibility
What is being tested?
The study tests two tools: 'Hello', a serious game, and The Conversation Project Starter Kit against a general conversation game to engage people in end-of-life discussions and motivate them to plan their care preferences ahead of time.See study design
What are the potential side effects?
Since this trial involves conversation-based tools rather than medical interventions, traditional side effects are not applicable. However, participants may experience emotional discomfort discussing end-of-life issues.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below
Select...
I am over 18 and belong to an underserved community.
Select...
I can speak and read English or Spanish.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~6 months post-intervention
This trial's timeline: 3 weeks for screening, Varies for treatment, and 6 months post-intervention for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Rates of Completion of a Visually Verified Advance Directive
Secondary outcome measures
Advance Care Planning Engagement Survey
Rates of Other Advance Care Planning (ACP) behaviors
Other outcome measures
Acceptability of Intervention Measure
Communication Quality Analysis (CQA) Measure
Conversation Satisfaction Questionnaire
+6 more

Trial Design

3Treatment groups
Active Control
Placebo Group
Group I: Group 1:Advance care planning conversation game, 'Hello'Active Control1 Intervention
The 'Hello' game is a commercially available serious game that consists of 32 questions prompting players to share their values, goals, and beliefs about end-of-life issues. The game is played with 4 - 5 players, with each receiving a game booklet and chips. A play reads the first question in the book. Then each player writes down their answers individually and takes turns sharing their answers with the group. Players control what they share, how long they share and when to move to the next questions. During the conversation, plays can acknowledge others for a thoughtful, poignant or even funny comments by giving them a chip. A pre-game coin flip determines whether the player with the most chips wins the game (heads) or player with the least chips win (tails) the game. Other names; previously name "My Gift of Grace"
Group II: Group 2: The Conversation Project (CP) Starter KitActive Control1 Intervention
The 'CP Starter Kit' (available for free online) is an 11-page workbook with open- ended prompts to consider one's values and preferences for end-of-life care, who to talk with about one's wishes, and suggestions on how to do so.
Group III: Group 3: Control Arm (Placebo control game, 'Table Topics')Placebo Group1 Intervention
A placebo/attention control l conversation game called 'Table Topics' will be used. Table Topics is a general conversation starter game that is unrelated to advance care planning. It involves answering open-ended questions in a group setting about a variety of topics.

Find a Location

Who is running the clinical trial?

Milton S. Hershey Medical CenterLead Sponsor
491 Previous Clinical Trials
2,797,305 Total Patients Enrolled
Hospice Foundation of AmericaUNKNOWN
1 Previous Clinical Trials
1,122 Total Patients Enrolled
University of KentuckyOTHER
184 Previous Clinical Trials
225,066 Total Patients Enrolled

Media Library

Group 1:Advance care planning conversation game, 'Hello' Clinical Trial Eligibility Overview. Trial Name: NCT04612738 — N/A
Disease Research Study Groups: Group 1:Advance care planning conversation game, 'Hello', Group 2: The Conversation Project (CP) Starter Kit, Group 3: Control Arm (Placebo control game, 'Table Topics')
Disease Clinical Trial 2023: Group 1:Advance care planning conversation game, 'Hello' Highlights & Side Effects. Trial Name: NCT04612738 — N/A
Group 1:Advance care planning conversation game, 'Hello' 2023 Treatment Timeline for Medical Study. Trial Name: NCT04612738 — N/A

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Are there any open slots for interested individuals to join this clinical trial?

"Affirmative. The trial, which was initially listed on March 19th 2022, is currently seeking 1500 volunteers from 2 distinct sites according to information published on clinicaltrials.gov."

Answered by AI

How many participants are enrolled in this clinical investigation?

"Affirmative. The details available on clinicaltrials.gov suggest that this trial is presently recruiting 1500 participants from two different medical facilities. This project was originally shared with the public on March 19th 2021 and has since been updated as recently as October 10th 2022."

Answered by AI

Who else is applying?

What site did they apply to?
St. Mary's Health System
Atrium Health Wake Forest Baptist
What portion of applicants met pre-screening criteria?
Met criteria
Did not meet criteria
~717 spots leftby Jan 2026